Sweden's Ambea Q1 sales slightly beat estimates

Ambea publ AB

07/05/2026 06:10

Overview

Sweden care provider's Q1 net sales rose 16% yr/yr, slightly beating analyst expectations

Adjusted EBITA margin improved to 9.0% from 8.4% yr/yr

EPS increased to SEK 2.03 from SEK 1.39 yr/yr, driven by organic and acquired growth

Outlook

Company expects operational improvements in Norway to gradually contribute to earnings in H2 2026

Result Drivers

EXPANSION OF CARE PLACES - Co cited new contracts and openings for nursing and LSS homes as supporting growth in the quarter

ACQUISITIONS AND INTEGRATION - Co said acquired growth and integration of previous acquisitions contributed to results

OPERATIONAL IMPROVEMENTS - Co reported focus on larger units and efficiency measures, particularly in Norway, with expected gradual earnings impact

Company press release: ID:nWkr8K23sz

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
Slight Beat*
SEK 4.22 bln
SEK 4.19 bln (3 Analysts)
Q1 Adjusted EPS
SEK 2.03
Q1 EBIT
SEK 356 mln


*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the healthcare facilities & services peer group is "buy."

Wall Street's median 12-month price target for Ambea publ AB is SEK168.50, about 25.1% above its May 6 closing price of SEK134.70

The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 13 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)